A clinical-stage biotechnology company focused on developing targeted therapies for cancer and other serious diseases. Its pipeline historically centered on oncology drug candidates, with value largely tied to clinical trial outcomes, regulatory milestones, and partnerships. Investors track the comp...
5 members of Congress have disclosed 5 trades in Sunesis Pharmaceuticals Inc (SNSS), a Healthcare company. The buy/sell breakdown shows 5 purchases versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2025-09-25 | Rohit Khanna | buy | $1K – $15K |
| 2019-04-23 | Michael Patrick Guest | buy | $15K – $50K |
| 2012-11-05 | CAROLYN MCCARTHY | buy | $1K – $15K |
| 2006-03-09 | Vern Buchanan | buy | $1K – $15K |
| 2003-08-11 | Todd Rokita | buy | $1K – $15K |